NEWS SUMMARY: N/A. Whether inflation will not rise or whether the Fed will be forced to cut rates in September is not so clear anymore The release of July’s industrial production prices, speeding up significantly more than expected, suggests that companies are indeed seeing the inflationary pressure from tariffs but not yet passed on to final prices, which could also have a negative impact on their margins in the 3Q’25. Following the data release, with weekly jobless claims also easing slightl...
COMPAÑÍAS QUE APARECEN EN EL INFORME: N/A Igual ya no está tan claro que la inflación no vaya a subir o que la Fed tenga que bajar tipos en septiembre La publicación del Precio de la Producción Industrial de julio en EE.UU., acelerándose sensiblemente más de lo esperado, apunta a que las empresas sí estarían sintiendo ya las presiones inflacionistas de los aranceles, pero que todavía no las han trasladado a los precios finales, lo que además podría incidir negativamente en sus márgenes en 3T’25...
NEWS SUMMARY: N/A. Greater expectations of rate cuts fuel stock markets Following the good inflation data released in the US, the Secretary of the Treasury, Scott Bessent, demanded new rate cuts of more than 150bps this year, starting with -50bps in September (R. Bostic, Fed member, stated he would see a -25bps cut appropriate in 2025 and thanks to the strength of the job market the Fed could still wait before cutting rates). Against this backdrop and in the absence of additional references, th...
NEWS SUMMARY: ACS. Ibex ended last week with daily gains Last week ended without relevant corporate results or macroeconomic data and with the implementation of tariff not entailing market volatility. The focus will now be on the US inflation (Tuesday) and peace talks in Ukraine between the US and Russia (Friday). The Ibex registered the best week in the past 4 months, ending above 14,800 points, returning to annual highs and near 2007 highs. Thus, in the STOXX 600 almost all sectors (16/20) en...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACS. EUROPA: VINCI. El Ibex cierra un pleno de subidas semanal Terminó la semana sin datos macro ni resultados empresariales de relevancia, y sin que la entrada en vigor de los aranceles trajera volatilidad a los mercados. Ahora toda la atención estará en la inflación en EE.UU. (martes) y las conversaciones de paz en Ucrania entre EE.UU. y Rusia (viernes). El Ibex cerró su mejor semana en 4 meses, renovando máximos anuales por encima de los 14.800 p...
NEWS SUMMARY: N/A. European markets ignore D. Trump D. Trump’s latest threats to the euro zone through higher tariffs did not have any impact on stock markets, which continued to climb as seen earlier this week, with the Ibex hitting again 2008 highs. Thus, in the STOXX 600 Energy and Real Estate saw the biggest gains vs. Pharma and Technology that were the worst performers. On the macro side, in the euro zone, June’s retail sales climbed more than expected. In Germany, June’s factory orders s...
NEWS SUMMARY: IBERDROLA, SOLARIA. Calm on stock markets European stock markets saw a decreasing performance with low volume where the earnings calendar and the possible rate cut by the Fed in September continued to set the pace. Thus, in the STOXX 600 most sectors (16/20) ended with gains, led by Autos and Basic Resources vs. Consumer Goods and Utilities that were the worst performers. On the macro side, in the euro zone, July’s final services PMI was cut although remained at levels consistent ...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: IBERDROLA, SOLARIA. EUROPA: AHOLD DELHAIZE, BAYER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 2T’25 que se publicarán en España y Europa en los próximos días. Poco movimiento en los mercados Jornada de más a menos y de escaso volumen en las bolsas europeas, donde el calendario de Rdos. y la posible baja...
A director at Sacyr S.A. sold 302,864 shares at 3.670EUR and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
NEWS SUMMARY: CELLNEX, IBERDROLA, REDEIA, SANTANDER. Trade matters put Europe in the red once again European stock markets fell due to trade matters. After the 01 August deadline passed, a 35% tariff was placed on Canada, 50% on Brazil, 25% on India, 20% on Taiwan and 39% on Switzerland, with another 69 trade partners facing tariffs between 10-41% if new agreements are not reached. As for Mexico, the country will continue to have a 25% tariff due to fentanyl, 25% on automobiles and 50% on steel...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX, IBERDROLA, REDEIA, SANTANDER. EUROPA: AB INBEV, AXA, BAYER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 2T’25 que se publicarán en España y Europa en los próximos días. Europa vuelve a pérdidas por el tema comercial Cesiones en las bolsas europeas por el tema comercial. Tas vencer el deadline de...
2Q'25 vs. 2Q'24 Results Sales: € 12.318 Bn (+22.7% vs. +23.4% BS(e) and +18.4% consensus); EBITDA: € 735.0 M (+5.6% vs. +5.3% BS(e) and +5.7% consensus); EBIT: € 472.0 M (-1.7% vs. -2.6% BS(e) and +0.4% consensus); Net Profit: € 259.0 M (+8.4% vs. -20.7% BS(e) and -18.9% consensus); 1H'25 vs. 1H'24 Results Sales: € 24.108 Bn (+28.6% vs. +29.0% BS(e) and +26.3% consensus); EBITDA: € 1.434 Bn (+23.9% vs. +23.7% BS(e) and +24.0% consensus); EBIT: € 942.0 M (+16.7% vs. +16.2% BS(e) and +18.0% consen...
Rdos. 2T'25 vs 2T'24: Ventas: 12.318 M euros (+22,7% vs +23,4% BS(e) y +18,4% consenso); EBITDA: 735,0 M euros (+5,6% vs +5,3% BS(e) y +5,7% consenso); EBIT: 472,0 M euros (-1,7% vs -2,6% BS(e) y +0,4% consenso); BDI: 259,0 M euros (+8,4% vs -20,7% BS(e) y -18,9% consenso); Rdos. 1S'25 vs 1S'24: Ventas: 24.108 M euros (+28,6% vs +29,0% BS(e) y +26,3% consenso); EBITDA: 1.434 M euros (+23,9% vs +23,7% BS(e) y +24,0% consenso); EBIT: 942,0 M euros (+16,7% vs +16,2% BS(e) y +18,0% consenso); BDI: 4...
2Q'25 vs. 2Q'24 Results Sales: € 906.35 M (-2.1% vs. -1.7% BS(e)); EBITDA: € 57.4 M (+51.1% vs. +7.7% BS(e)); EBIT: € 27.45 M (+85.5% vs. +48.1% BS(e)); Net Profit: € -7.85 M (€ -29.5 M in 1H'24 vs. € -8.04 M BS(e)); 1H'25 vs. 1H'24 Results Sales: € 1.689 Bn (-1.8% vs. -1.6% BS(e)); EBITDA: € 84.1 M (+46.3% vs. +17.6% BS(e)); EBIT: € 46.25 M (+139.6% vs. +111.0% BS(e)); Net Profit: € -29.65 M (€ -34.2 M in 1H'24 vs. € -29.84 M BS(e));
Rdos. 2T'25 vs 2T'24: Ventas: 906,35 M euros (-2,1% vs -1,7% BS(e); EBITDA: 57,4 M euros (+51,1% vs +7,7% BS(e)); EBIT: 27,45 M euros (+85,5% vs +48,1% BS(e)); BDI: -7,85 M euros (-29,5 M euros en 1S'24 vs -8,04 M euros BS(e)); Rdos. 1S'25 vs 1S'24: Ventas: 1.689 M euros (-1,8% vs -1,6% BS(e)); EBITDA: 84,1 M euros (+46,3% vs +17,6% BS(e)); EBIT: 46,25 M euros (+139,6% vs +111,0% BS(e)); BDI: -29,65 M euros (-34,2 M euros en 1S'24 vs -29,84 M euros BS(e)).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.